To establish patient protections with respect to highly rebated drugs.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To establish patient protections with respect to highly rebated drugs., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Finance, Labor.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H33D87E04A0D04C20ABEBE1756FAACC1A: 1. Short title This Act may be cited as the Fairness for Patient Medications Act.
- Section HBA3B391F0E71481E93FC36E581A51CB3: 2. Requirements with respect to cost-sharing for highly rebated drugs Part D of title XXVII of the Public Health Service Act (42 U.S.C. 300gg–111 et seq.) is...
- Section H5E1F09ABA282467B9EFC477208AC184C: 2799A–11. Requirements with respect to cost-sharing for highly rebated drugs No later than April 1, 2024, and annually thereafter, the Secretary shall certify...
- Section H35A7A1DF21F849D39FA5D783E8B839A9: 725. Requirements with respect to cost-sharing for highly rebated drugs No later than April 1, 2024, and annually thereafter, the Secretary shall certify (or...
- Section H0EF5E8320DD542D2AC3DD64E159C3A6E: 9826. Requirements with respect to cost-sharing for highly rebated drugs No later than April 1, 2024, and annually thereafter, the Secretary shall certify (or...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To establish patient protections with respect to highly rebated drugs., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Finance, Labor
Primary Purpose
This bill, To establish patient protections with respect to highly rebated drugs., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Legislative Progress
IntroducedMr. Griffith introduced the following bill; which was referred to …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_secretary"
- → The Secretary identified in the operative section
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology